New Mesothelioma Combination Therapy Shows Excellent Results

The outcomes of the Phase I clinical trial indicate that patients on pemetrexed, as opposed to those on other current chemotherapy treatments, can tolerate higher doses of the drug along with simultaneous radiation therapy. The combination of the elevated doses and the radiation treatments increases the strength of the therapeutic regimen.